** Shares of India's Laurus Labs LAUL.NS jump 6.1% to 1,168.20 rupees
** Drugmaker reported quarterly revenue from operations at 18.12 billion rupees ($190.92 million), up 5.3% y/y, driven by a richer product mix
** Net profit up ~19.5% y/y
** BOB Capital Markets sees profitability likely improving; raises FY27 and FY28 EPS estimates by 8% and 1%, respectively
** Brokerage expects sales and EBITDA to grow at a CAGR of 15% and 19%, respectively
** Trading vols at 3 mln shares, vs 30-day avg of 1.8 mln shares
** LAUL rated "hold" on average by 13 analysts, median PT: 1,045 rupees - data compiled by LSEG
** YTD, stock up ~4.8%
($1 = 94.9100 Indian rupees)
(Reporting by Bipasha Dey in Bengaluru)
((Bipasha.Dey@thomsonreuters.com;))